|
|||||
|
|
Clinical phase II and III studies of an AS03‐adjuvanted H5N1 influenza vaccine produced in an EB66® cell culture platform |
|
| Authors: | Masafumi Endo Mitsuyoshi Tanishima Kayo Ibaragi Kenshi Hayashida Tadashi Fukuda Tetsuro Tanabe Takeshi Naruse Yoichiro Kino Kohji Ueda |
| Abstract: | |
| Keywords: | AS03 EB66® cells H5N1 influenza |